← Back to opportunities

Helix Biotech Biosimilar mRNA Vaccines

UK Health Security Agency

Buyer Contact Info

Buyer Name: UK Health Security Agency

Buyer Address: 10 South Colonnade, London, UKI42, E14 4PU, United Kingdom

Contact Email: commercial.preparednessandcountermeasures@ukhsa.gov.uk

Status
complete
Procedure
direct
Value
150000.0 GBP
Published
12 Aug 2025, 09:18
Deadline
n/a
Contract Start
07 Sep 2025, 23:00
Contract End
07 Sep 2027, 22:59
Category
n/a
CPV
33651600 - Vaccines
Region
n/a
Awarded To
Helix Biotech, Inc.
Official Source
Open Find a Tender

Description

Vaccine mimic materials-comprising messenger RNA (mRNA) and lipid nanoparticles (LNPs)-from Helix-Biotech.

Linked Documents

No linked documents found for this notice.

Opportunity Context

Lots

Lot 1 Status: complete

Lot 1 SME Suitable: Yes

Documents

Document Description: Not published

Awards

Award Title: Helix Biotech Biosimilar mRNA Vaccines

Raw Notice JSON

Expand raw payload 
{
  "awards": [
    {
      "aboveThreshold": true,
      "contractPeriod": {
        "endDate": "2027-09-07T23:59:59+01:00",
        "startDate": "2025-09-08T00:00:00+01:00"
      },
      "documents": [
        {
          "datePublished": "2025-08-12T10:18:36+01:00",
          "description": "Transparency notice on Find a Tender",
          "documentType": "awardNotice",
          "format": "text/html",
          "id": "047894-2025",
          "noticeType": "UK5",
          "url": "https://www.find-tender.service.gov.uk/Notice/047894-2025"
        }
      ],
      "id": "1",
      "items": [
        {
          "additionalClassifications": [
            {
              "description": "Vaccines",
              "id": "33651600",
              "scheme": "CPV"
            }
          ],
          "id": "1",
          "relatedLot": "1"
        }
      ],
      "mainProcurementCategory": "goods",
      "milestones": [
        {
          "dueDate": "2025-09-01T23:59:59+01:00",
          "id": "1",
          "status": "scheduled",
          "type": "futureSignatureDate"
        }
      ],
      "relatedLots": [
        "1"
      ],
      "status": "pending",
      "suppliers": [
        {
          "id": "GB-PPON-PCMD-6995-GBGZ",
          "name": "Helix Biotech, Inc."
        }
      ],
      "title": "Helix Biotech Biosimilar mRNA Vaccines",
      "value": {
        "amount": 150000.0,
        "amountGross": 180000.0,
        "currency": "GBP"
      }
    }
  ],
  "buyer": {
    "id": "GB-PPON-PBMQ-7576-DVGW",
    "name": "UK Health Security Agency"
  },
  "date": "2025-08-12T10:18:36+01:00",
  "id": "047894-2025",
  "initiationType": "tender",
  "language": "en",
  "ocid": "ocds-h6vhtk-0585bd",
  "parties": [
    {
      "address": {
        "country": "GB",
        "countryName": "United Kingdom",
        "locality": "London",
        "postalCode": "E14 4PU",
        "region": "UKI42",
        "streetAddress": "10 South Colonnade"
      },
      "contactPoint": {
        "email": "commercial.preparednessandcountermeasures@ukhsa.gov.uk"
      },
      "details": {
        "classifications": [
          {
            "description": "Public authority - central government",
            "id": "publicAuthorityCentralGovernment",
            "scheme": "UK_CA_TYPE"
          }
        ],
        "url": "https://www.gov.uk/government/organisations/uk-health-security-agency"
      },
      "id": "GB-PPON-PBMQ-7576-DVGW",
      "identifier": {
        "id": "PBMQ-7576-DVGW",
        "scheme": "GB-PPON"
      },
      "name": "UK Health Security Agency",
      "roles": [
        "buyer"
      ]
    },
    {
      "address": {
        "country": "US",
        "countryName": "United States",
        "locality": "Knoxville",
        "postalCode": "37918",
        "region": "US",
        "streetAddress": "1460 Breda Drive"
      },
      "contactPoint": {
        "email": "info@helix-biotech.com"
      },
      "details": {
        "scale": "sme",
        "vcse": false
      },
      "id": "GB-PPON-PCMD-6995-GBGZ",
      "identifier": {
        "id": "PCMD-6995-GBGZ",
        "scheme": "GB-PPON"
      },
      "name": "Helix Biotech, Inc.",
      "roles": [
        "supplier"
      ]
    }
  ],
  "tag": [
    "award",
    "contract"
  ],
  "tender": {
    "description": "Vaccine mimic materials-comprising messenger RNA (mRNA) and lipid nanoparticles (LNPs)-from Helix-Biotech.",
    "documents": [
      {
        "description": "Not published",
        "documentType": "conflictOfInterest",
        "id": "conflictOfInterest"
      }
    ],
    "id": "C371747",
    "legalBasis": {
      "id": "2023/54",
      "scheme": "UKPGA",
      "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
    },
    "lots": [
      {
        "id": "1",
        "status": "complete",
        "suitability": {
          "sme": true,
          "vcse": true
        }
      }
    ],
    "procurementMethod": "direct",
    "procurementMethodDetails": "Direct award",
    "procurementMethodRationale": "Helix-Biotech Inc. is the only supplier capable of delivering the required vaccine mimic materials (mRNA encapsulated in LNPs) with validated equivalence to licensed Pfizer-style COVID-19 vaccines. Their proprietary methodology and formulation capability are not available from other suppliers, nor covered under any current public procurement frameworks.",
    "procurementMethodRationaleClassifications": [
      {
        "id": "singleSuppliersTechnicalReasons"
      }
    ],
    "riskDetails": "A valid and current Cyber Essentials Certificate is required.",
    "status": "complete",
    "title": "Helix Biotech Biosimilar mRNA Vaccines"
  }
}